Aussie Study Shows Abraxane Extends Survival With Pancreatic Cancer
This article was originally published in PharmAsia News
Executive Summary
An Australian study of the drug abraxane so far has shown it to be a life-extender for patients with pancreatic cancer when used as chemotherapy in addition to standard treatment.